Modulation of paclitaxel resistance by annexin IV in human cancer cell lines

British Journal of Cancer

Volumn 83, Issue 1, 2000, Pages 83-88

  Han, E Kyu Ho ^a   Tahir, S K ^a   Cherian, S P ^a   Collins, N ^a   Ng, S C ^a  

^a Cancer Research Department 4N6   (United States)

Author keywords

Annexin; Antimitotic; Drug resistance; Paclitaxel

Indexed keywords

A 204197; ANTIBODY; ANTIMITOTIC AGENT; COMPLEMENTARY DNA; LIPOCORTIN 2; LIPOCORTIN 4; NUCLEAR PROTEIN; PACLITAXEL; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANNEXIN A4; BLOTTING, WESTERN; COLCHICINE; COLONIC NEOPLASMS; DNA, COMPLEMENTARY; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NOCODAZOLE; PACLITAXEL; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUBULIN MODULATORS; TUMOR CELLS, CULTURED;

EID: 0034078907     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1311     Document Type: Article

References (34)

1. Barwise JL and Walker JH (1996) Annexins II, IV, V and VI relocate in response to rises in intracellular calcium in human foreskin fibroblasts. J Cell Sci 109: 247-255
2. Benz J and Hofmnn A (1997) Annexins: from structure to function. Biol Chem 78: 177-183
3. Blagosklonny MV, Schulte TW, Nguyen P, Mimnaugh EG, Trepel J and Neckers L (1995) Taxol induction of p21WAFl and p53 requires c-rat-l. Cancer Res 55: 4623-4626
4. Cabral F, Abraham I and Gottesman MM (1981) Isolation of a taxol-resistant Chinese hamster ovary cell mutant that has an alteration in α-tubulin. Proc Natl Acad Sci USA 78: 4388-4391
5. Cole SPC, Pinkoski MJ, Bhardwaj G and Deeley RG (1992) Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br J Cancer 65: 498-502
6. Dubois T, Oudinet JP, Mira JP and Russo-Marie F (1996) Annexins and protein kinase C. Biochim Biophys Acta 1313: 290-294
7. Germann UA (1996) P-glycoprotein-a mediator of multidrug resistance in tumour cells. Eur J Cancer 32A: 927-944
8. Giannakakou P, Sackett DL, Kang YK, Zhan Z, Buters JTM, Fojo T and Poruchynsky MS (1997) Paclitaxel-resistant human ovarian cancer cells have mutant β-tubulins that exhibit impaired paclitaxel-driven polymerization J Biol Chem 272: 17118-17125
9. Gottesman MM and Pastan I (1998) The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163-12166
10. Gottesman MM and Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Res Biochem 62: 385-427
11. Haber M, Burkhart CA, Regl DL, Madaliglio J and Norris MD and Horwitz SB (1995) Altered expression of Mβ2, the class II β-tubulin isotype, in a murine J744.2 cell line with a high level of taxol resistance. J Biol Chem 270: 31269-31277
12. Han EK-H, Sgambato A, Jiang W, Zhang Y-U, Santella RM, Doki Y, Cacace A, Schieren I and Weinstein IB (1995) Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 10: 953-961
13. Han EK-H, Begemann M, Sgambato A, Soh J-W, Xing W-Q and Weinstein IB (1996) Increased expression of cyclin D1 in a murine mammary epithelial cell line inhibits growth and enhances apoptosis. Cell Growth Differ 7: 699-710
14. Han EK-H, Gehrke L, Tahir SK, Credo RB, Cherian SP, Sham H, Rosenberg SH and Ng SC (1999) Modulation of multidrug resistance by α-tubulin in taxol resistant human lung cancer cell line. Eur J Cancer (in press)
15. Kavallaris M, Kuo DY-S, Burkhart CA, Regl DL, Norris MD, Haber M and Horwitz SB (1997) Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific β-tubulin isotypes J Clin Invest 100. 1282-1293
16. Kavallaris M, Burkhart CA and Horwitz SB (1999) Antisense oligonuclotides to class III β-tubulin sensitize drug-resistant cells to taxol. Br J Cancer 80: 1020-1025
17. Lee JS, Paull K, Alvarez M, Hose C, Monks A, Grever M, Fojo AT and Bates SE (1994) Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Mol Pharm 46: 627-638
18. Lehnert M (1996) Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 32A: 912-920
19. Mohiti J, Caswell AM and Walker JH (1995) Calcium-induced relocation of annexins IV and V in the human osteosarcoma cell line MG-63. Mol Mem Biol 12: 321-329
20. Nygren P, Larsson R, Gruber A, Peterson C and Bergh J (1991) Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterized by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression. Br J Cancer 64: 1011-1018
21. O'Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250: 4007-4021
22. Ranganathan S, Dexter DW, Benetatos CA and Hudes GR (1988) Cloning and sequencing of human βIII-tubulin cDNA: induction of βIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Biochim Biophy Acta 1395: 237-245
23. Ranganathan S, Dexter DW, Benetatos CA, Chapman AE, Tew KD and Hudes GR (1996) Increase of βIII-and βIV-tubulin isotypes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res 56: 2584-2589
24. Ranganathan S, Benetatos CA, Colarusso PJ, Dexter DW and Hudes GR (1998) Altered β-tubulin isotype expression in paclitaxel-resistant human prostate carcinoma cells Br J Cancer 77: 562-566
25. Raynal P, Kuijpers G, Rojas E and Pollard HR (1996) A rise in nuclear calcium translocate annexins IV and V to the nuclear envelope. FEBS Lett 392: 263-268
26. Rowinsky EK, and Donehower RC (1995) Paclitaxel (Taxol) N Engl J Med (1995) 332: 1004-1014
27. Rowinsky EK, Onetto N, Canetta RM and Arbuck SG (1992) Taxol: the first of the taxanes, an important new class of antitumor agents. Sem Oncol 19: 646-662
28. Sjolin C, Stendahl O and Dahlgren C (1994) Calcium-induced translocation of annexins to subcellular organelles of human neutrophils. Biochem J 300: 325-330
29. Schibler MJ and Cabral F (1986) Taxol-dependent mutants of Chinese hamster ovary cells with alterations in alpha-and beta-tubulin. J Cell Biol 102: 1522-1531
30. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Keney S and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112
31. Smith PD and Moss SE (1994) Structural evoluation of the annexin supergene family Trends in Genetics 10: 241-246
32. Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T and Wimalasena J (1998) Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem 273: 4928-4936
33. Wolfson M, Yang CPH and Horwitz SB (1997) Taxol induces tyrosine phosphorylation of She and its association with Grb2 in murine RAW 264.7 cells. Int J Cancer 70: 248-252
34. Yang CPH, Galbiati F, Volonte D, Horwitz SB and Lisanti MP (1998) Upregulation of caveolin-1 and caveola organelles in taxol-resistant A549 cells. FEBS Lett 439: 368-372